A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
A warm and pleasant evening for many. Clear and cool overnight.
Continuing to be a fine and dry day across the country with lengthy sunny spells.
Leicester midfielder Andy King believes Wales can defy the odds at Euro 2016.